Related Experiment Videos
Allergen avoidance to reduce asthma-related morbidity
The New England Journal of Medicine
|September 10, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.
BMC gastroenterology·2014
Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2013
Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema.
Expert review of clinical immunology·2011
Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.
The Journal of allergy and clinical immunology·2011
Ecallantide for the treatment of acute attacks in hereditary angioedema.
The New England journal of medicine·2010
The diagnosis and management of anaphylaxis practice parameter: 2010 update.
The Journal of allergy and clinical immunology·2010
Phase 2b Trial of a NaV1.8 Inhibitor for Acute Pain.
The New England journal of medicine·2026
Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.
The New England journal of medicine·2026
Primary Pulmonary Diffuse Large B-cell Lymphoma.
Clinical nuclear medicine·2026
Influence of genetic polymorphisms on omalizumab clinical response in pediatric severe asthma: a pilot study.
Frontiers in pharmacology·2026
Multimodal Imaging Features of Systemic Sarcoidosis: FDG PET/CT and Cardiac PET/MRI Findings.
Clinical nuclear medicine·2026
RAG1 deficiency durably alters dermal group 2 innate lymphoid cells and modifies contact hypersensitivity.
Frontiers in immunology·2026